Your browser doesn't support javascript.
SARS-CoV-PLpro-Inhibitoren als mögliche Breitspektrum-Virostatika.
Hammerschmidt, Stefan Josef; Müller, Patrick; Schirmeister, Tanja.
  • Hammerschmidt SJ; Institut für Pharmazeutische und Biomedizinische Wissenschaften (IPBW), Johannes Gutenberg-Universität Mainz, Staudinger Weg 5, D-55128 Mainz, Deutschland.
  • Müller P; Institut für Pharmazeutische und Biomedizinische Wissenschaften (IPBW), Johannes Gutenberg-Universität Mainz, Staudinger Weg 5, D-55128 Mainz, Deutschland.
  • Schirmeister T; Institut für Pharmazeutische und Biomedizinische Wissenschaften (IPBW), Johannes Gutenberg-Universität Mainz, Staudinger Weg 5, D-55128 Mainz, Deutschland.
Biospektrum (Heidelb) ; 27(3): 254-256, 2021.
Article in German | MEDLINE | ID: covidwho-1384644
ABSTRACT
The SARS-CoV-encoded papain-like cysteine protease (PLpro) plays crucial roles in viral replication and maturation processes. It is required to cleave the precursor polyproteins into functional proteins. Thus, it is considered to be a promising target for developing specific drugs. For rational optimization of hit compounds, information about the structure-activity relationship (SAR) is fundamental. Herein, we characterize isoindolines as a new class of PLpro inhibitors.

Full text: Available Collection: International databases Database: MEDLINE Language: German Journal: Biospektrum (Heidelb) Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: German Journal: Biospektrum (Heidelb) Year: 2021 Document Type: Article